[Skip to Content]
[Skip to Content Landing]
Contempo Updates
September 27, 2000

Obstructive Sleep Apnea

Author Affiliations

Author Affiliations: Departments of Otolaryngology-Head and Neck Surgery (Dr Piccirillo), Neurology (Dr Duntley), and Medicine (Dr Schotland), and the Division of Pulmonary and Critical Care Medicine (Dr Schotland), Washington University School of Medicine, St Louis, Mo.

JAMA. 2000;284(12):1492-1494. doi:10.1001/jama.284.12.1492

Obstructive sleep apnea (OSA) syndrome affects an estimated 2% to 4% of the US adult population.1 It is part of a collection of sleep-related breathing disorders, that include snoring, upper airway resistance syndrome,2 and obesity-hypoventilation syndrome.3 The clinical sequelae of untreated OSA syndrome are often severe and include daytime hypersomnolence, cognitive impairment, systemic hypertension, pulmonary hypertension, myocardial infarction, cardiac arrhythmias, and increased risk of motor vehicle crashes.4,5 Unfortunately, the majority of patients with OSA syndrome remain undiagnosed and untreated.6

First Page Preview View Large
First page PDF preview
First page PDF preview
×